Sooty bark disease in BC: A cause of a rare form of hypersensitivity pneumonitis

Sooty bark disease is a rare form of hypersensitivity pneumonitis that is caused by exposure to spores of Cryptostroma corticale. C. corticale is a fungus endemic to eastern North America but invasive in parts of western and central Europe, where it infects certain broadleaf trees, specifically maples. The fungus colonizes trees via airborne spores and can lead to wasting of the bark in a disease state known as sooty bark disease.[1,2] The descriptor “sooty” refers to the mats of fungal spores that can lead to a blackened appearance and friable texture of infected trees’ bark.

In the summer of 2022, staff from the Canadian Forest Service (part of Natural Resources Canada) and the British Columbia Ministry of Forests, Lands and Natural Resource Operations discovered five cases of sooty bark disease in urban trees in the Victoria and greater Vancouver areas and positively identified C. corticale. While known to be present in Washington state since 1969,[3] sooty bark disease had not been previously reported in BC.

Sooty bark disease

Hypersensitivity pneumonitis is a form of interstitial lung disease, characterized by inflammation and fibrosis of the lung interstitium, driven by an immune response to an inhaled antigen.[4] In sooty bark disease, these antigens are C. corticale spores and/or mycelia.[5] Acute symptoms of sooty bark disease, which may appear after hours or days of exposure, include coughing, wheezing, fatigue, diarrhea, nausea, and vomiting. Continued exposure to fungal spores can cause immune-mediated lung remodeling with cough, shortness of breath, and systemic signs such as weight loss and fever.[5,6]

Hypersensitivity pneumonitis is rare, with an annual incidence of one to two per 100 000.[4] Sooty bark disease is even more rare—we found five relevant case reports but no descriptions or estimates of incidence.[6-10] All reports involved prolonged proximity to wood or bark contaminated with C. corticale. Three described cases in loggers,[6-8] one described a case in a horticulturist,[10] and one described a case in an orchid grower who cultivated over 1000 orchids with bark chips.[9] We did not find documented cases of sooty bark disease due to inhalation of windblown spores or from casual exposure, and we found no description or report of risk to the general public.

Risk of sooty bark disease in BC

At present, with only a small number of cases of sooty bark disease detected in BC, the risk to BC residents is low. However, the prevalence of trees affected by sooty bark disease is likely to increase. Sooty bark disease was detected in Seattle in 2020.[11] It has since been detected multiple times and is an emerging concern for ornamental tree health.[12] This is likely due in part to recent heat and drought affecting the Pacific Northwest. Heat- and drought-stressed trees are more susceptible to C. corticale, and warmer and especially drier weather may lead to an increased incidence of sooty bark disease.[5,13]

Over time, if sooty bark disease becomes more prevalent in BC, there may be some risk to occupational groups such as foresters, arborists, and carpenters who work extensively with wood. In addition, infected trees will need to be detected, disposed of, and diverted from chipping or use as mulch. The risk to the public would likely remain very low except for those who engage in activities that bring them into prolonged and frequent contact with wood or bark.

To manage and understand this risk, the Canadian Forest Service is developing a surveillance program based on a network of provincial, municipal, and private stakeholders to monitor for trees infected with C. corticale. They will share results of this surveillance with the BC Centre for Disease Control and WorkSafeBC to disseminate to the public and employers, along with appropriate risk and mitigation information.
—Ali Okhowat, MD, MPH, CCFP
Clinical Instructor and Co-Lead, R3 Enhanced Skills in Global Health Program, Faculty of Medicine, University of British Columbia
—Christopher Carlsten, MD, MPH
Professor of Medicine, University of British Columbia
—Joey Tanney, PhD
Research Scientist, Pacific Forestry Centre, Canadian Forest Service, Natural Resources Canada
—Nicolas Feau, PhD
Research Scientist, Pacific Forestry Centre, Canadian Forest Service, Natural Resources Canada
—David McVea, MD, PhD
Public Health Physician, Environmental Health Services, BC Centre for Disease Control

hidden


This article is the opinion of the BC Centre for Disease Control and has not been peer reviewed by the BCMJ Editorial Board.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

1.    Schlößer R, Bien S, Langer GJ, Langer EJ. Fungi associated with woody tissues of Acer pseudoplatanus in forest stands with different health status concerning sooty bark disease (Cryptostroma corticale). Mycol Prog 2023;22:13. doi: 10.1007/s11557-022-01861-6.

2.    Cochard B, Crovadore J, Bovigny PY, et al. First reports of Cryptostroma corticale causing sooty bark disease in Acer sp. in Canton Geneva, Switzerland. New Dis Rep 2015;31:8. doi: 10.5197/j.2044-0588.2015.031.008.

3.    Goree H. Occurrence of Cryptostroma corticale in northwestern United States. Plant Dis Rep 1969;53:87.

4.    Leone PM, Richeldi L. Current diagnosis and management of hypersensitivity pneumonitis. Tuberc Respir Dis (Seoul) 2020;83:122-131. doi: 10.4046/trd.2020.0012.

5.    Kespohl S, Riebesehl J, Grüner J, Raulf M. Impact of climate change on wood and woodworkers—Cryptostroma corticale (sooty bark disease): A risk factor for trees and exposed employees. Front Public Health 2022;10:973686. doi: 10.3389/fpubh.2022.973686.

6.    Wenzel FJ, Emanuel DA. The epidemiology of maple bark disease. Arch Environ Health 1967;14:385-389. doi: 10.1080/00039896.1967.10664759.

7.    Emanuel DA, Wenzel FJ, Lawton BR. Pneumonitis due to Cryptostroma corticale (maple-bark disease). N Engl J Med 1966;274:1413-1418. doi: 10.1056/NEJM196606232742504.

8.    Towey JW, Sweany HC, Huron WH. Severe bronchial asthma apparently due to fungus spores found in maple bark. JAMA 1932;99:453-459. doi: 10.1001/jama.1932.02740580021005.

9.    Shepherd GM, Michelis MA, Macris NT, Smith JP. Hypersensitivity pneumonitis in an orchid grower associated with sensitivity to the fungus Cryptostroma corticale. Ann Allergy 1989;62:522-525.

10.    Plate HP, Schneider R. Ein fall von asthmaartiger allergie, verursacht durch den pilz Cryptostroma corticale. Nachr Dtsch Pflanzenschutzd 1965;7:100-101.

11.    Washington State Department of Natural Resources. Forest health highlights in Washington / 2020. 2021. Accessed 20 December 2024. www.dnr.wa.gov/publications/rp_fh_2020_forest_health_highlights.pdf.

12.    Washington State University. Sooty bark disease. Accessed 20 December 2024. https://ppo.puyallup.wsu.edu/sbd.

13.    Ogris N, Brglez A, Piškur B. Drought stress can induce the pathogenicity of Cryptostroma corticale, the causal agent of sooty bark disease of sycamore maple. Forests 2021;12:377. doi: 10.3390/f12030377.

Ali Okhowat, MD, MPH, CCFP, Christopher Carlsten, MD, MPH, Joey Tanney, PhD, Nicolas Feau, PhD, David A. McVea, MD, PhD. Sooty bark disease in BC: A cause of a rare form of hypersensitivity pneumonitis. BCMJ, Vol. 67, No. 1, January, February, 2025, Page(s) - BC Centre for Disease Control.



Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply